EN
HI
Procter & Gamble Health Share Price
550540.50 (0.74%)
NSE
BSE
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 19 Nov, 2026, Procter & Gamble Health stock price is ₹5505. During the trading session, the stock has moved between an intraday low of ₹5360.50 and an intraday high of ₹5543.50. Over the last 52 weeks, Procter & Gamble Health has traded between ₹4707.00 and ₹6975.00.
The stock has recorded a trading volume of 21,566 shares,. Its Average Traded Price (ATP) is ₹5431.08, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹5505.00.
Procter & Gamble Health has an upper circuit limit of ₹6557.00 and a lower circuit limit of ₹4372.00. The total value traded stands at ₹11.71 CR, and the delivery percentage for the day is 51.28%.
The stock is currently traded with a market lot size of 1. Procter & Gamble Health also offers a dividend yield of 0%.
Procter & Gamble Health Share Price Chart
Procter & Gamble Health Share Key Metrics
Volume
21566.00
Market Cap
9137.96 CR
LTQ@LTP
1@5505.00
ATP
5431.08
Var Margin
14.2 %
Circuit Range
4372-6557
Delivery %
51.28 %
Value
11.71 CR
ASM/GSM
No
Market Lot
1
Procter & Gamble Health Resistance and Support
Pivot 5513.5
Resistance
First Resistance
5574.5
Second Resistance
5684.5
Third Resistance
5745.5
Support
First Support
5403.5
Second Support
5342.5
Third Support
5232.5
Procter & Gamble Health Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
51.82%
Mutual Fund
10.64%
Insurance
3.77%
Foreign Institutional Investors
7.01%
Domestic Institutional Investors
0.31%
Retail
26.46%
Others
-0.01%
Total Promoters
MAR '24
51.82%
JUN '24
51.82%
SEP '24
51.82%
DEC '24
51.82%
Procter & Gamble Health Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-02 | Quarterly Results |
| 2026-08-06 | Quarterly Results |
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-06 | Quarterly Results & Interim Dividend |
| 2025-11-05 | Quarterly Results & Interim Dividend |
| 2025-08-01 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-12 | Quarterly Results & Interim Dividend |
| 2024-11-04 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-08-27 | 2026-08-27 | View More |
Procter & Gamble Health News
Procter & Gamble Health Ltd - 500126 - Press Release
Procter & Gamble Health announced its results for the second quarter ended Sept 30, 2026. Sales grew 18% YoY to Rs.376 cr and PAT rose 26% YoY to Rs.112 cr, driven by strong retail execution and productivity improvements.
Nov 02 2026 14:53:07
Procter & Gamble Health Ltd - 500126 - Board Meeting Outcome for Outcome For The Board Meeting Held On November 2, 2026
Procter & Gamble Health reported Q2 FY27 revenue of ₹382.49 crore and net profit of ₹111.51 crore, up 25.9% YoY. Total expenses for the quarter increased to ₹236.33 crore.
Nov 02 2026 14:43:33
Procter & Gamble Health Management
| Name | Position |
|---|---|
| Zeal Rupani | Company Secretary & Compliance Officer |
| S Madhavan | Chairperson |
Procter & Gamble Health Similar Stocks
Paras Healthcare Ltd.
829.80
-51.05 (5.80%)
Blue Jet Healthcare Ltd.
518.45
7.85 (1.54%)
Jupiter Life Line Hospitals Ltd.
289.60
-0.15 (0.05%)
Strides Pharma Science Ltd.
958.10
-24.00 (2.44%)
Aarti Pharmalabs Ltd.
1013.40
-2.50 (0.25%)
Healthcare Global Enterprises Ltd.
599.35
23.75 (4.13%)
Thyrocare Technologies Ltd.
503.60
-3.35 (0.66%)
Suven Life Sciences Ltd.
265.65
-3.00 (1.12%)
Sanofi India Ltd.
3231.80
7.90 (0.25%)
Bliss GVS Pharma Ltd.
680.35
24.00 (3.66%)
Procter & Gamble Health FAQs
The Buying Price of Procter & Gamble Health share is 5505 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Procter & Gamble Health stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Procter & Gamble Health, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Procter & Gamble Health shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Procter & Gamble Health shares is 0. Useful to assess the stock's value relative to its book value.
To assess Procter & Gamble Health’s valuation compare Sector P/E, P/B which are 40.39 & 2.41 with sector averages, along with growth rates and financial metrics.
The Market Cap of Procter & Gamble Health is 9137.96 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Procter & Gamble Health share price is 6975.00 & 4707.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Procter & Gamble Health belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in PGHL
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC